David Roulois
PhD
Research Scientist
👥Biography 个人简介
David Roulois co-discovered the viral mimicry mechanism by which low-dose DNMT inhibitors reactivate ERVs to produce dsRNA that activates MDA5/MAVS innate immune signaling in cancer cells. This seminal finding explained how epigenetic therapy sensitizes tumors to immune checkpoint blockade and launched a new field of combination therapy approaches. His work continues to define the molecular mechanisms linking ERV reactivation to anti-tumor immunity.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 David Roulois 的研究动态
Follow David Roulois's research updates
留下邮箱，当我们发布与 David Roulois（INSERM / University of Rennes）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment